PTPN1 and ovarian cancer: In addition to PTP1b’s tumor suppressor activity in endothelial cells and fibroblasts, PTP1b has also been identified as a negative regulator of insulin-like growth factor receptor (IGFR) signaling that attenuates kinase signaling associated with survival and metastasis in ovarian cancer [34].